Published on 10 Apr 2024 on Seeking Alpha
Roche test wins CE Mark to identify metastatic breast cancer patients (OTCQX:RHHBY)
Roche obtained CE Mark for its HER2 test, making it the first companion diagnostic for HER2-low...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free